On the other hand, an upregulation of SVEP1 in CAFs compared to normal fibroblasts, and its involvement in chemoresistance to gemcitabine and cisplatin, has been recently described in urothelial bladder cancer [112]. This evidence concerns the gene SVEP1 and bladder transitional cell carcinoma.